Q4 2024 Earnings Call Transcript February 7, 2025 Byrna Technologies Inc. beats earnings expectations. Reported EPS is ...
Kenvue shows decent growth but struggles with profitability. Find out why KVUE stock is a 'hold' as cost-cutting efforts face ...
Nomura Holdings, Inc. ( NYSE: NMR) Q3 2025 Earnings Conference Call February 5, 2025 3:00 AM ET Masao Muraki - SMBC Nikko Securities Natsumu Tsujino - BofA Securities Kazuki Watanabe - Daiwa ...
With AI becoming more accessible than ever, businesses now have powerful tools to automate tasks, optimize decision-making, ...
Gov. Whitmer is expected to propose a road funding plan next week that includes an increase in the 6% corporate income tax, ...
Consolidated revenue from operations rose by 17.7 per cent year-on-year (YoY), reaching Rs 41,464.98 crore, compared to Rs 35,218.32 crore in the previous year ...
Fortive targets companies with reputable brand names, large installed bases, and strong cash flows. Management has focused particularly on boosting recurring revenue in its portfolio, which has ...
In Money today: the best mortgage rates and where they're expected to go this year following the base rate cut; Netflix has ...
As the fifth anniversary of the legalization of “adult use cannabis in Illinois” rolls around, the state is celebrating the fourth year of record-setting sales.
Neurocrine Biosciences exceeded earnings expectations for Q4 2024, driven by robust sales from key product Ingrezza, while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results